MLchartDataset catalogue

zoptarelin doxorubicin

Term · Oncology and biomedicine · MLC-T-ONC-017713

A peptide agonist of the gonadotropin releasing hormone-1 receptor (GnRH-1R) that is conjugated to the anthracycline antibiotic doxorubicin with potential antineoplastic activity. Zoptarelin doxorubicin binds to GnRH-1Rs, which may be highly expressed on endometrial and ovarian tumor cell membrane surfaces, and is internalized. Once inside the cell, the doxorubicin moiety of this agent intercalates into DNA and inhibits the topoisomerase II activity, which may result in the inhibition of tumor cell DNA replication and tumor cell proliferation.

Table 1. Record
IdentifierMLC-T-ONC-017713
FieldOncology and biomedicine
Synonymsdoxorubicin-LHRH agonist conjugate AEZS-108; doxorubicin-GNRH agonist conjugate AEZS-108
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-017713",
  "term": "zoptarelin doxorubicin",
  "field": "Oncology and biomedicine",
  "definition": "A peptide agonist of the gonadotropin releasing hormone-1 receptor (GnRH-1R) that is conjugated to the anthracycline antibiotic doxorubicin with potential antineoplastic activity. Zoptarelin doxorubicin binds to GnRH-1Rs, which may be highly expressed on endometrial and ovarian tumor cell membrane surfaces, and is internalized. Once inside the cell, the doxorubicin moiety of this agent intercalates into DNA and inhibits the topoisomerase II activity, which may result in the inhibition of tumor cell DNA replication and tumor cell proliferation.",
  "synonyms": [
    "doxorubicin-LHRH agonist conjugate AEZS-108",
    "doxorubicin-GNRH agonist conjugate AEZS-108"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/zoptarelin-doxorubicin/"
}

Record 17,701 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.